Volume 17, Number 3—March 2011
Dispatch
Multidrug-Resistant Genotypes of Plasmodium falciparum, Myanmar
Table 1
Gene | Haplotype | Codon† | Haplotype prevalence,‡ % |
||
---|---|---|---|---|---|
2007, n = 41 | 2008, n = 40 | 2009, n = 36 | |||
Pfdhfr (51, 59, 108, 164) |
Wild-type | NCSI | 2.4 | – | – |
Double mutations | NRNI | 9.8 | 5.0 | – | |
Triple mutations | NRNL | 31.7a | 25.0b | 36.1a | |
IRNI | 14.6a | 7.5b | 16.7a | ||
Quadruple mutations |
IRNL |
41.5a |
62.5b |
47.2a |
|
Pfdhps (436, 437, 540, 581) | Wild-type | SAKA | 2.4 | – | 2.8 |
Single mutation | SGKA | – | 2.5 | 2.8 | |
Double mutations | SGEA | 9.8 | 2.5 | – | |
SGNA | 2.4 | – | – | ||
Triple mutations | SGEG | 26.8a | 35.0b | 19.4c | |
SGNG | 2.4 | 2.5 | – | ||
AGEA | 48.8a | 45.0a | 52.8a | ||
AGNA | 7.3 | – | 8.3 | ||
Quadruple mutations | AGEG | – | 10.0 | 11.1 | |
AGNG | – | 2.5 | 2.8 |
*Pfdhfr, Plasmodium falciparum dihydrofolate reductase; Pfdhps, P. falciparum dihydropoteroate synthase; –, no such haplotype detected.
†Codons in boldface indicate mutated amino acids.
‡χ2 test was performed with all data points of the 2 genes, which showed that overall haplotype prevalence differed significantly between the years (χ2 test, p<0.0001, χ2 = 76.49, df = 28). Major dhfr and dhps haplotypes were individually compared. For each haplotype (in the same row), the labeling by different letters denotes significant difference between the years (χ2 test, p<0.05).
1These authors contributed equally to this article.
Page created: July 25, 2011
Page updated: July 25, 2011
Page reviewed: July 25, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.